Answers are grounded in this paper and cite their sources.
There are several studies on the benefits of using TNFα antagonists in the treatment of psoriasis, but few studies addressing the interaction of these drugs with chronic infections. We report the case of a 52-year-old patient diagnosed with psoriasis refractory to traditional systemic agents, who was treated with biologic therapies. After one year of treatment with biologic agents, the patient was diagnosed with Chagas Disease.
No takes yet. Share an insight, caveat, or question.
Navarrete‐Dechent et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: